Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers

Journal of Infectious Diseases

Volumn 183, Issue 2, 2001, Pages 343-346

  Jacobson, Jeffrey M ^a   Greenspan, John S ^b   Spritzler, John ^d   Fox, Lawrence ^e   Fahey, John L ^c   Jackson, J Brooks ^f   Chernoff, Miriam ^d   Wohl, David A ^g   Pulvirenti, Joseph J ^h   Hooton, Thomas M ⁱ   Shikuma, Cecilia ^j   Greenspan, D ^b   Aweeka, F ^b   Simpson, D ^a   Wu, A ^k   Ketter, N ^e   Trapnell, C ^e   Purdue, L ^e   McFarland, J ^l   Levy, W ^l   Jones, G ^m   Bardequez, A ⁿ   Clark, R ^o   Quesada, N ^c   Andrulis, P J ^p   Drulak, M W ^p   Luykx, K ^q   Van der Horst, C ^r   Forstat, S ^b   Kessler, H ^h   Royer, B A ^s   Ogata Arakaki, D ^t   Currier, J S ^u   Clemente, V T ^u   Vasquez, G J ^v   Cruz Ortiz, M ^v   Delapenha, R ^w   Butler, Y ^w   Wheat, L J ^x   Zwickl, B W ^x   Soiero, R ^y   Stein, D ^y   Basgoz, N ^z   Doweiko, J ^z   McAuliffe, V ^aa   Dowling, J ^aa   Hewitt, R ^ab   Blair, D ^ab   Canmann, S ^ac   Connick, E ^ac   Raffanti, S P ^ad   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h RUSH MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF HAWAII   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^m FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

ⁿ New Jersey SEEDS   (United States)

^o TULANE UNIVERSITY   (United States)

^p Andrulis Pharmaceuticals Corp   (United States)

^q MOUNT SINAI MEDICAL CENTER   (United States)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

^s UNIVERSITY OF WASHINGTON   (United States)

^t UNIVERSITY OF HAWAII   (United States)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^w HOWARD UNIVERSITY   (United States)

^x INDIANA UNIVERSITY   (United States)

^y ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^z HARVARD MEDICAL SCHOOL   (United States)

^aa NEW YORK UNIVERSITY   (United States)

^ab UNIVERSITY AT BUFFALO   (United States)

^ac UNIVERSITY OF COLORADO   (United States)

^ad MEHARRY MEDICAL COLLEGE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

APHTHOUS ULCER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOUTH ULCER; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; SENSORY NEUROPATHY; TREATMENT OUTCOME; ULCER HEALING;

ANTI-HIV AGENTS; DOUBLE-BLIND METHOD; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECURRENCE; STOMATITIS, APHTHOUS; THALIDOMIDE; TREATMENT FAILURE;

EID: 0035863461     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317928     Document Type: Article

References (10)

1. Recurrent aphthous ulcers in association with HIV infection description of ulcer types and analysis of T lymphocytes subsets
2. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
3. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection
4. Combining dependent tests with incomplete repeated measurements
5. The empirical distribution function with arbitrarily grouped, censored and truncated data
6. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS)
7. Crossover study of thalidomide vs. placebo in severe recurrent aphthous stomatitis
8. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome - A randomized, double-blind, placebo-controlled trial